Learn more

IMMUTEP SAS

Overview
  • Total Patents
    56
  • GoodIP Patent Rank
    26,378
  • Filing trend
    ⇩ 60.0%
About

IMMUTEP SAS has a total of 56 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOGEN INTERNAT NEUROSCIENCE GMBH, BIOGEN INT NEUROSCIENCE GMBH and BIOGEN IDEC INTERNAT NEUROSCIENCE GMBH.

Patent filings per year

Chart showing IMMUTEP SASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Brignone Chrystelle 27
#2 Triebel Frederic 17
#3 Triebel Frédéric 16
#4 Chrystelle Brignone 7
#5 Jia Justin Xiaoqing 7
#6 Chen Min 6
#7 Frédéric Triebel 5
#8 Blattler Walter A 4
#9 Frey Gerhard Johann 3
#10 Justin Xiaoqing Jia 3

Latest patents

Publication Filing date Title
GB202018062D0 Treatment of cancer
GB202014412D0 Treatment of coronavirus
WO2020221928A1 Anti-lag-3 binding molecules
WO2020221924A1 Assays
CN108204958A binding assay
AU2016316730A1 Anti-LAG-3 Antibodies
US2018271940A1 Combined preparations for the treatment of cancer or infection
KR20160093076A Combined preparations for the treatment of cancer